SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLINIA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.425
AS - Asia 12.561
EU - Europa 6.266
SA - Sud America 2.032
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 288
OC - Oceania 18
Totale 49.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.879
SG - Singapore 4.696
CN - Cina 2.993
BR - Brasile 1.567
VN - Vietnam 1.481
UA - Ucraina 1.125
IT - Italia 1.102
DE - Germania 1.099
HK - Hong Kong 1.071
TR - Turchia 850
GB - Regno Unito 651
FI - Finlandia 450
BD - Bangladesh 384
PL - Polonia 358
SE - Svezia 356
FR - Francia 355
RU - Federazione Russa 341
IN - India 242
CA - Canada 223
MX - Messico 210
JP - Giappone 208
AR - Argentina 161
ID - Indonesia 157
ZA - Sudafrica 92
ES - Italia 82
NL - Olanda 82
IQ - Iraq 78
EC - Ecuador 67
CO - Colombia 66
AT - Austria 56
PK - Pakistan 52
BE - Belgio 48
UZ - Uzbekistan 46
VE - Venezuela 46
CL - Cile 40
SA - Arabia Saudita 40
MA - Marocco 39
LT - Lituania 35
TN - Tunisia 33
PY - Paraguay 31
KE - Kenya 27
PH - Filippine 27
IR - Iran 25
JM - Giamaica 25
EG - Egitto 22
UY - Uruguay 22
MY - Malesia 21
CZ - Repubblica Ceca 20
ET - Etiopia 18
JO - Giordania 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
CR - Costa Rica 16
PS - Palestinian Territory 16
IL - Israele 15
PE - Perù 15
AZ - Azerbaigian 14
NP - Nepal 14
RO - Romania 14
DZ - Algeria 13
KR - Corea 13
HN - Honduras 12
AL - Albania 11
BO - Bolivia 10
CH - Svizzera 10
KZ - Kazakistan 10
TH - Thailandia 10
GR - Grecia 9
OM - Oman 9
SV - El Salvador 9
GT - Guatemala 8
NG - Nigeria 8
NI - Nicaragua 8
TW - Taiwan 8
HU - Ungheria 7
LB - Libano 7
BG - Bulgaria 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
PA - Panama 6
RS - Serbia 6
BB - Barbados 5
DK - Danimarca 5
GA - Gabon 5
MD - Moldavia 5
PT - Portogallo 5
SN - Senegal 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
CI - Costa d'Avorio 4
GD - Grenada 4
GE - Georgia 4
IE - Irlanda 4
KW - Kuwait 4
LV - Lettonia 4
LY - Libia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 48.527
Salva come PNG Salva come JPEG
Città #
Fairfield 3.010
Singapore 2.932
Ashburn 2.731
Woodbridge 2.710
Houston 1.612
San Jose 1.465
Seattle 1.259
Jacksonville 1.245
Ann Arbor 1.190
Chandler 1.097
Hong Kong 1.049
Cambridge 997
Wilmington 997
Santa Clara 889
Beijing 879
Ho Chi Minh City 464
Izmir 450
Dallas 448
Council Bluffs 396
Los Angeles 372
Nanjing 359
Warsaw 341
Hanoi 333
New York 310
Princeton 287
Addison 248
San Diego 248
Lauterbourg 239
Ferrara 235
Munich 202
Boardman 201
Tokyo 196
Milan 183
São Paulo 151
Helsinki 140
Shanghai 126
Nanchang 119
Buffalo 117
Mexico City 114
Orem 107
Jakarta 102
London 95
Shenyang 93
Dearborn 91
Hebei 84
The Dalles 84
Tianjin 84
Hefei 80
Toronto 77
Bremen 71
Turku 70
Atlanta 69
Denver 68
Chicago 67
Da Nang 67
Falls Church 65
Brooklyn 61
Haiphong 61
Mountain View 59
Rome 59
Jiaxing 57
San Mateo 57
Frankfurt am Main 56
Johannesburg 56
Stockholm 55
Jinan 52
Changsha 50
Rio de Janeiro 50
Montreal 49
Redwood City 47
Falkenstein 45
Brussels 44
Chennai 43
Boston 42
Columbus 42
Amsterdam 41
Moscow 41
Nuremberg 40
Guangzhou 39
Kunming 39
Phoenix 39
Tashkent 39
Mumbai 38
Belo Horizonte 37
San Francisco 37
Bologna 36
Manchester 35
Baghdad 33
Poplar 33
Norwalk 31
Dong Ket 30
Ankara 29
Ningbo 29
Brasília 28
Des Moines 28
Vienna 28
Hangzhou 27
Orange 27
Philadelphia 27
Porto Alegre 27
Totale 33.538
Salva come PNG Salva come JPEG
Nome #
Loss of miR-204 expression is a key event in melanoma 289
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 276
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 275
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 260
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 259
Correlation of expression between different IMAGE clones from the same UniGene cluster 258
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 258
MicroRNA expression profiling in human Barrett's carcinogenesis. 256
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 256
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 253
MicroRNA Expression Signatures in Solid Malignancies 252
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 241
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 241
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples 240
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 240
Identification of microRNA activity by Targets' Reverse EXpression. 237
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 232
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 231
Reprogramming of miRNA networks in cancer and leukemia 228
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 228
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 226
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 225
Microevolution in Ferrara: Isonymy 1890–1990 225
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 224
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 224
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 221
GAMES identifies and annotates mutations in next-generation sequencing projects 221
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 220
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 219
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 218
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 218
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 218
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 218
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 217
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 215
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 214
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 213
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 211
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 211
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 210
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 210
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 207
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 206
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer 205
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 204
Espressione dei MicroRNA nei carcinomi mammari 203
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 202
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 200
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 200
TOM: Transcriptomics of OMIM. 199
CG Dinucleotides of class II MHC genes are mutation hot-spots 198
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations 198
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 197
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 197
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 197
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 196
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 195
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 195
Partial gene deletion in a family with factor X deficiency 195
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 194
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 192
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 192
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 191
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 191
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 191
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 190
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 190
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 189
Expression profiles of craniosynostosis-derived fibroblasts 186
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 186
The role of microRNA genes in papillary thyroid carcinoma 185
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 184
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 184
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 184
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 183
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 182
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 181
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 179
GOAL: automated gene ontology analisys of expression profiles. 177
MicroRNA profiles discriminate among colon cancer metastasis 177
The network of non-coding RNAs in cancer drug resistance 176
Modulation of mismatch repair and genomic stability by miR-155 176
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 175
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 174
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 174
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 174
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 173
A microRNA expression signature of human solid tumors defines cancer gene targets 173
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 172
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 172
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 169
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 167
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 167
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 167
The network of non-coding RNAs and their molecular targets in breast cancer 167
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 167
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials 166
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 166
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways 165
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 164
Totale 20.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.425
Totale 209.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.023 0 363 351 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20255.665 155 154 476 211 697 441 186 393 931 626 768 627
2025/202616.943 1.506 749 1.585 2.156 2.337 990 1.991 990 1.669 1.740 825 405
2026/2027978 451 527 0 0 0 0 0 0 0 0 0 0
Totale 49.008